Pharm prime vendor fleet
Ended Awarded
- Contract number
- SPE2DU26F0B85
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,520
Award facts
- Contract value 100% obligated
- $4,520.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,520.40 by the Defense Logistics Agency on October 29, 2025. This firm fixed-price delivery order, designated as a Pharmaceutical Prime Vendor Fleet contract, represents a specific purchase issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative. The contract was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group maintains a critical role in the federal pharmaceutical supply chain, supplying a comprehensive range of products including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support Department of Defense healthcare operations.
This delivery order is issued under the umbrella of the DLA's $30.3 billion Pharmaceutical Prime Vendor Global Program Generation V acquisition strategy, which establishes multiple regional prime vendor contractors to supply pharmaceutical products to military healthcare facilities worldwide. DMS Pharmaceutical Group's underlying IDC, awarded on November 13, 2025, carries a ceiling value of $499.999 billion with an ultimate completion date of December 31, 2036, and is structured as a 30-month base period with three 30-month option periods. The company's demonstrated performance on numerous delivery orders across diverse therapeutic categories positions it as a capable supplier of the specialized pharmaceutical requirements necessary for the Department of Defense military medical system globally.
Quick answers
Who was awarded contract SPE2DU26F0B85?
SPE2DU26F0B85 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DU26F0B85 worth?
The government has obligated $4,520 on SPE2DU26F0B85.
Is contract SPE2DU26F0B85 an order under another contract?
Yes. SPE2DU26F0B85 is a delivery order under SPE2DU25D9803, an indefinite delivery contract.
Was contract SPE2DU26F0B85 competed?
The extent of competition for SPE2DU26F0B85 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award